203 related articles for article (PubMed ID: 22955689)
1. Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI.
Cetin M; Kocaman SA; Canga A; Kırbaş A; Yılmaz A; Erdoğan T; Akgül O; Uğurlu Y; Durakoğlugil ME
Herz; 2013 Mar; 38(2):202-9. PubMed ID: 22955689
[TBL] [Abstract][Full Text] [Related]
2. Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Yang L; Dong H; Lu H; Liao Y; Zhang H; Xu L; Tan Y; Cao S; Tan J; Fu S
Medicine (Baltimore); 2019 Mar; 98(12):e14920. PubMed ID: 30896649
[TBL] [Abstract][Full Text] [Related]
3. Impact of D-dimer level on postinterventional coronary flow and in-hospital MACE in ST-segment elevation myocardial infarction.
Sarli B; Akpek M; Baktir AO; Sahin O; Saglam H; Arinc H; Odabasi H; Dogan S; Kurtul S; Dogan Y; Kaya MG
Herz; 2015 May; 40(3):507-13. PubMed ID: 24441391
[TBL] [Abstract][Full Text] [Related]
4. Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction.
Hedegaard A; Ripa RS; Johansen JS; Jørgensen E; Kastrup J
Scand J Clin Lab Invest; 2010 Apr; 70(2):80-6. PubMed ID: 20102300
[TBL] [Abstract][Full Text] [Related]
5. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
[TBL] [Abstract][Full Text] [Related]
6. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.
Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö
Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of YKL-40 increases in patients with acute myocardial infarction.
Nøjgaard C; Høst NB; Christensen IJ; Poulsen SH; Egstrup K; Price PA; Johansen JS
Coron Artery Dis; 2008 Jun; 19(4):257-63. PubMed ID: 18480670
[TBL] [Abstract][Full Text] [Related]
8. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction.
Çanga A; Durakoğlugil ME; Erdoğan T; Kirbaş A; Yilmaz A; Çiçek Y; Ergül E; Çetin M; Kocaman SA
J Cardiol; 2012 Nov; 60(5):355-60. PubMed ID: 22727437
[TBL] [Abstract][Full Text] [Related]
10. YKL-40, a novel marker of cardiovascular complications, is related to kidney function in heart transplant recipients.
Przybyłowski P; Janik L; Wasilewski G; Nowak E; Koźlik P; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2860-3. PubMed ID: 25380936
[TBL] [Abstract][Full Text] [Related]
11. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.
Ege M; Güray U; Güray Y; Yılmaz MB; Demirkan B; Saşmaz A; Korkmaz S
Anadolu Kardiyol Derg; 2011 May; 11(3):213-7. PubMed ID: 21421510
[TBL] [Abstract][Full Text] [Related]
12. Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease.
Zheng JL; Lu L; Hu J; Zhang RY; Zhang Q; Chen QJ; Shen WF
Atherosclerosis; 2010 Jun; 210(2):590-5. PubMed ID: 20056225
[TBL] [Abstract][Full Text] [Related]
13. YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease.
Wang Y; Ripa RS; Johansen JS; Gabrielsen A; Steinbruchel DA; Friis T; Bindslev L; Haack-Sørensen M; Jørgensen E; Kastrup J
Scand Cardiovasc J; 2008 Oct; 42(5):295-302. PubMed ID: 18615353
[TBL] [Abstract][Full Text] [Related]
14. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI.
Akpek M; Kaya MG; Uyarel H; Yarlioglues M; Kalay N; Gunebakmaz O; Dogdu O; Ardic I; Elcik D; Sahin O; Oguzhan A; Ergin A; Gibson CM
Atherosclerosis; 2011 Nov; 219(1):334-41. PubMed ID: 21831375
[TBL] [Abstract][Full Text] [Related]
15. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
Wang JW; Chen YD; Wang CH; Zhu XL
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
18. Relationship of admission hematological indexes with myocardial reperfusion abnormalities in acute ST segment elevation myocardial infarction patients treated with primary percutaneous coronary interventions.
Maden O; Kacmaz F; Selcuk H; Selcuk MT; Aksu T; Tufekcioglu O; Senen EK; Balbay Y; Ilkay E
Can J Cardiol; 2009 Jun; 25(6):e164-8. PubMed ID: 19536384
[TBL] [Abstract][Full Text] [Related]
19. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cetin MS; Ozcan Cetin EH; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
Thromb Res; 2015 Sep; 136(3):599-605. PubMed ID: 26251078
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil/Lymphocyte Ratio as a Predictor of In-Hospital Major Adverse Cardiac Events, New-Onset Atrial Fibrillation, and No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction.
Wagdy S; Sobhy M; Loutfi M
Clin Med Insights Cardiol; 2016; 10():19-22. PubMed ID: 26884687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
